New Drug Approved for Deadly Lung Condition, First in Over a Decade

(MEDPAGE Today) – Nerandomilast (JASCAYD) tablets approved by the FDA for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in more than a decade, the agency announced Tuesday. Main support for preferential…